This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (56)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Dermatology  • Photosensitivity Disorders  • Phototherapy  • Psychopharmacology  • Psychiatry, Other  • Alert me on articles by topic

Alexander Neumeister, MD; Erick H. Turner, MD; Jefferey R. Matthews, MD; Teodor T. Postolache, MD; Ronald L. Barnett, PhD; Manfred Rauh, MD; Rina G. Vetticad; Siegfried Kasper, MD; Norman E. Rosenthal, MD

Arch Gen Psychiatry. 1998;55:524-530.

Background  Although hypotheses about the therapeutic mechanism of action of light therapy have focused on serotonergic mechanisms, the potential role, if any, of catecholaminergic pathways has not been fully explored.

Methods  Sixteen patients with seasonal affective disorder who had responded to a standard regimen of daily 10000-lux light therapy were enrolled in a double-blind, placebo-controlled, randomized crossover study. We compared the effects of tryptophan depletion with catecholamine depletion and sham depletion. Ingestion of a tryptophan-free amino acid beverage plus amino acid capsules was used to deplete tryptophan. Administration of the tyrosine hydroxylase inhibitor -methyl-para-tyrosine was used to deplete catecholamines. Diphenhydramine hydrochloride was used as an active placebo during sham depletion. The effects of these interventions were evaluated with measures of depression, plasma tryptophan levels, and plasma catecholamine metabolites.

Results  Tryptophan depletion significantly decreased plasma total and free tryptophan levels. Catecholamine depletion significantly decreased plasma 3-methoxy-4-hydroxyphenylethyleneglycol and homovanillic acid levels. Both tryptophan depletion and catecholamine depletion, compared with sham depletion, induced a robust increase (P<.001, repeated-measures analysis of variance) in depressive symptoms as measured with the Hamilton Depression Rating Scale, Seasonal Affective Disorder Version.

Conclusions  The beneficial effects of light therapy in the treatment of seasonal affective disorder are reversed by both tryptophan depletion and catecholamine depletion. These findings confirm previous work showing that serotonin plays an important role in the mechanism of action of light therapy and provide new evidence that brain catecholaminergic systems may also be involved.

From the National Institute of Mental Health, Clinical Psychobiology Branch, Bethesda, Md (Drs Neumeister, Turner, Matthews, Postolache, Barnett, and Rosenthal and Ms Vetticad); Department of General Psychiatry, Vienna University, Vienna, Austria (Drs Neumeister and Kasper); and Department of Pediatrics, University of Erlangen, Erlangen, Germany (Dr Rauh).

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Phototherapy-Mediated Syndrome of Inappropriate Secretion of Antidiuretic Hormone in an In Utero Selective Serotonin Reuptake Inhibitor-Exposed Newborn Infant
Vanhaesebrouck et al.
Pediatrics 2005;115:e508-e511.
ABSTRACT | FULL TEXT  

Light therapy and the management of winter depression
Eagles
Adv. Psychiatr. Treat. 2004;10:233-240.
ABSTRACT | FULL TEXT  

Seasonal affective disorder
Eagles
Br. J. Psychiatry 2003;182:174-176.
FULL TEXT  

Fc{epsilon}RI Induces the Tryptophan Degradation Pathway Involved in Regulating T Cell Responses
von Bubnoff et al.
J. Immunol. 2002;169:1810-1816.
ABSTRACT | FULL TEXT  

Dietary Supplements and Natural Products as Psychotherapeutic Agents
Fugh-Berman and Cott
Psychosom. Med. 1999;61:712-728.
ABSTRACT | FULL TEXT  

Other articles noted
Evid. Based Ment. Health 1998;1:100-100.
FULL TEXT